Urology Medical News about bladder gel

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Topical overactive bladder gel found well-tolerated, effective
Urology Times, 06/30/09

Guttman C - Compared with patch systems, the gel formulation is free of enhancers or occlusion that can worsen skin-site reactions, and also avoids production of the primary oxybutynin metabolite through first-pass metabolism. This pharmacokinetic profile may explain why there is less dry mouth with the topical gel.

<< Previous
Factors associated with phosphodiesterase type 5 inhibitor...

Next >>
Prospective pharmacologic therapies for the overactive bladder

The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09 Relevance Score: 46%%

192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/09 Relevance Score: 46%%

Significant Association of XPD Codon 312 Single Nucleotide Polymorphism with Bladder Cancer Susceptibility in Taiwan
Anticancer Research, 11/10/09 Relevance Score: 46%%

Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09 Relevance Score: 46%%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09 Relevance Score: 46%%